Internal Medicine, Medical Oncology · Colchester, VT
NPI
1982603221
Since 2005
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
792 College Pkwy, Suite 207
Colchester, VT, 05446
Phone (802) 655-3400
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.2M
111,917 services
Medicare patients, 2024
524
Average age 75
Drug cost, 2024
$3.5M
1,218 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dennis A Sanders was code J9271 (injection, pembrolizumab, 1 mg), 17,800 times for 18 patients. In total Dennis A Sanders billed 111,917 services in 106 codes, and Medicare paid $3.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-10-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 17,800 | 18 | $43.89 | $781K |
| J9312 Injection, rituximab, 10 mg | Office | 4,300 | 11 | $61.43 | $264K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 3,300 | 16 | $6.39 | $21K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,883 | 44 | $0.09 | $170 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,240 | 36 | $0.70 | $874 |
| 99214 Office E&M - Established | Office | 1,229 | 415 | $87.89 | $108K |
| 36415 Venipuncture Blood Collection | Office | 1,027 | 341 | $8.63 | $8,860 |
| 85025 Blood Count | Office | 984 | 334 | $7.59 | $7,469 |
| 80053 Clinical Chemistry | Office | 730 | 278 | $10.35 | $7,556 |
| J1750 Injection, iron dextran, 50 mg | Office | 560 | 21 | $13.49 | $7,554 |
| 96413 Chemotherapy Administration | Office | 436 | 83 | $96.32 | $42K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 411 | 105 | $0.50 | $204 |
| 99215 Office E&M - Established | Office | 369 | 165 | $128.91 | $48K |
| 96375 Injection Administration | Office | 267 | 52 | $11.48 | $3,066 |
| J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 254 | 63 | $1.02 | $258 |
By year: 2022 $3.6M for 138,063 services; 2023 $3.1M for 108,426 services; 2024 $3.2M for 111,917 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,027 | 341 | $8.63 | $8,860 |
| 85025 Blood Count | 984 | 334 | $7.59 | $7,469 |
| 80053 Clinical Chemistry | 730 | 278 | $10.35 | $7,556 |
| 83615 Clinical Chemistry | 131 | 87 | $5.92 | $776 |
Medicare prescription drug claims, 2024
In 2024, the drug Dennis A Sanders prescribed most often to Medicare patients was Tamoxifen Citrate, with 201 prescriptions and refills. In total Dennis A Sanders wrote 1,218 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamoxifen Citrate Generic | 201 | 565 | 61 | $7,473 |
| Anastrozole Generic | 153 | 393 | 38 | $3,995 |
| Eliquis Apixaban | 75 | 88 | 15 | $51K |
| Hydroxyurea Generic | 72 | 143 | 17 | $2,123 |
| Imbruvica Ibrutinib | 42 | 51 | Under 11 | $602K |
| Prednisone Generic | 41 | 45 | Under 11 | $186 |
| Famotidine Generic | 37 | 55 | 14 | $311 |
| Abiraterone Acetate Generic | 36 | 36 | Under 11 | $54K |
| Letrozole Generic | 35 | 53 | Under 11 | $581 |
| Xtandi Enzalutamide | 35 | 41 | Under 11 | $595K |
| Morphine Sulfate Generic | 33 | 33 | Under 11 | $1,455 |
| Tagrisso Osimertinib Mesylate | 32 | 32 | Under 11 | $423K |
| Gabapentin Generic | 32 | 32 | Under 11 | $315 |
| Lorazepam Generic | 30 | 30 | 14 | $80.02 |
| Levothyroxine Sodium Generic | 25 | 29 | Under 11 | $161 |
Brand drugs: 349 claims; generic drugs: 869 claims; opioid claims: 75.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Dennis A Sanders were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.